Rugby Budesonide Nasal Spray - Allergy and Nasal Congestion Relief - Alcohol-Free - 0.285 Fl. Oz.
- NASAL ALLERGY SYMPTOM RELIEVER: Rugby's Budesonide Nose Spray is a trusted remedy for temporary relief from the following symptoms of hay fever and upper respiratory allergies: nasal congestion, runny nose, itchy nose, and sneezing.
- NASAL CONGESTION RELIEF: Our nasal spray has 120 metered sprays per bottle. It is free from alcohol, eggs, gluten, latex, peanuts, soy, and sugar.
- QUALITY FORMULATION: We maintain high standards of care through strict regulatory compliance to deliver carefully formulated, effective nasal spray. Each spray has 32 mcg of budesonide (glucocorticoid), a nasal allergy symptom reliever.
- HOW TO USE: For adults and children 12 years and older, spray 2 times into each nostril while sniffing gently once a day. Once allergy symptoms improve, reduce to 1 spray in each nostril daily. For children 6 to under 12 years old, spray 1 time into each nostril daily (with adult supervision).
- RUGBY LABORATORIES: At Rugby Laboratories, we believe wellness should be accessible to everyone. We pride ourselves on our legacy of delivering quality OTC and vitamin supplements.
Informazio garrantzitsua
Osagaiak
Budesonide 32 mcg
Lege oharra
FDAk ez ditu ebaluatu dieta-gehigarriei buruzko instrukzioak, eta ez dute diagnostikatu, tratatu, sendatu edo gaixotasun edo osasun-egoera saihesteko asmorik.
Produktuaren neurriak
1.5 x 1.5 x 4.8 inches; 1.13 ounces
Specifications
| Produktuen abantailak | Nasal Relief, Alergia-kontrola, Arnas-laguntza |
| Produktuaren erabilera espezifikoak | Fluxua, Alergia, Chest Congestion, Nasal Congestion |
| Iraungitze-data | 2026ko abendua |
| Elementuaren neurriak L X W X H | 1.5 X 1.5 X 4.8 hazbete |
| Produktu mota | Botikak |
| Elementuaren pisua | 1.13 Ontza |
| Brand | Rugby |
| Osagaiak | Budesonide 32 Mcg |
| Tags | |
|---|---|
| Tags | |
Your Dynamic Snippet will be displayed here...
This message is displayed because you did not provide both a filter and a template to use.









